Trades on 2 secondary markets

Antiva Biosciences

Antiva Biosciences is a clinical-stage biopharmaceutical company developing topical therapeutics that target oncogenic human papillomavirus (HPV) infections and the precancerous cervical lesions they cause, aiming to stop cervical cancer before it starts with at-home, non-surgical treatment. Its lea

minimal 8.1 / 100 0 APIs View provider profile →
CompanyBiotechnologyPharmaceuticalsHealthcareLife SciencesOncology

Antiva Biosciences is an API provider whose private shares are listed on 2 secondary markets: Forge Global, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.